Correlation Between Travere Therapeutics and Aptose Biosciences
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Aptose Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Aptose Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Aptose Biosciences, you can compare the effects of market volatilities on Travere Therapeutics and Aptose Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Aptose Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Aptose Biosciences.
Diversification Opportunities for Travere Therapeutics and Aptose Biosciences
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Travere and Aptose is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Aptose Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptose Biosciences and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Aptose Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptose Biosciences has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Aptose Biosciences go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Aptose Biosciences
Given the investment horizon of 90 days Travere Therapeutics is expected to generate 0.87 times more return on investment than Aptose Biosciences. However, Travere Therapeutics is 1.15 times less risky than Aptose Biosciences. It trades about 0.03 of its potential returns per unit of risk. Aptose Biosciences is currently generating about -0.15 per unit of risk. If you would invest 1,658 in Travere Therapeutics on August 31, 2024 and sell it today you would earn a total of 212.00 from holding Travere Therapeutics or generate 12.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Travere Therapeutics vs. Aptose Biosciences
Performance |
| Timeline |
| Travere Therapeutics |
| Aptose Biosciences |
Travere Therapeutics and Aptose Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Travere Therapeutics and Aptose Biosciences
The main advantage of trading using opposite Travere Therapeutics and Aptose Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Aptose Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will offset losses from the drop in Aptose Biosciences' long position.| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
| Aptose Biosciences vs. CytomX Therapeutics | Aptose Biosciences vs. Instil Bio | Aptose Biosciences vs. Spero Therapeutics | Aptose Biosciences vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |